SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-18-033269
Filing Date
2018-06-07
Accepted
2018-06-07 16:33:51
Documents
80
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv490022_10k.htm 10-K 1352781
2 EXHIBIT 10.34 tv490022_ex10-34.htm EX-10.34 314406
3 EXHIBIT 23.1 tv490022_ex23-1.htm EX-23.1 3014
4 EXHIBIT 31.1 tv490022_ex31-1.htm EX-31.1 10230
5 EXHIBIT 31.2 tv490022_ex31-2.htm EX-31.2 9682
6 EXHIBIT 32 tv490022_ex32.htm EX-32 5568
  Complete submission text file 0001144204-18-033269.txt   7684311

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acur-20171231.xml EX-101.INS 1611835
8 XBRL TAXONOMY EXTENSION SCHEMA acur-20171231.xsd EX-101.SCH 65873
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20171231_cal.xml EX-101.CAL 57368
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20171231_def.xml EX-101.DEF 393488
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20171231_lab.xml EX-101.LAB 480803
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20171231_pre.xml EX-101.PRE 457032
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10113 | Film No.: 18886871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences